The VTA Sues Trump Administration For Moving The PMTA Deadline Forward

Last March, the FDA issued its much-anticipated guidelines with regards to new restrictions on

vaping products. The draft had been released just weeks before Commissioner Scott Gottlieb’s

set exit, and was infact one of Gottlieb’s priorities, following the backlash he faced for

the alleged increase in teen vaping, which many conveniently blamed on the PMTA delay.

Amongst other things, this guidance had called for the ban of flavoured products with the

exception of tobacco, mint or menthol-flavored e-cigarettes from retail stores that minors can

access easily, such as convenience stores or gas stations.

 

Meanwhile last July, a court case which had been brought about by anti-tobacco and health

groups following the announcement of the initial PMTA delay (to 2022), had resulted in a

ruling requiring e-cig manufacturers to submit their PMTAs by May 2020.

To this effect, last week the VTA filed a lawsuit in response to this ruling in an attempt to

reverse it. The industry group called the expedited deadline, “arbitrary” and pointed out

that it is “impossible to meet for thousands of small and mid-sized vapor businesses.”

“The stark facts set forth in the Complaint are that, even with unlimited resources, there

are not enough labs, there are not enough subjects, and there are not enough hours in the day

to properly conduct the scientific inquiries that FDA only just laid out … by the May 2020

deadline,” said the VTA.  Enditem